In a significant advancement for the field of molecular oncology, a multi-disciplinary team of investigators from the Johns Hopkins Kimmel…
Read More

In a significant advancement for the field of molecular oncology, a multi-disciplinary team of investigators from the Johns Hopkins Kimmel…
Read More
A collaborative research effort led by scientists at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg School…
Read More
In a significant advancement for the field of oncology, investigators at the Johns Hopkins Kimmel Cancer Center and the Johns…
Read More
A landmark clinical guideline, published on June 9th in the esteemed journal Circulation, heralds a significant paradigm shift in the…
Read More
A groundbreaking clinical guideline published on June 9 in the esteemed journal Circulation heralds a significant shift in how prevalent…
Read More
Eli Lilly and Company, a global pharmaceutical leader, has significantly bolstered its commitment to the cutting-edge field of genetic medicines…
Read More
Eli Lilly and Company has announced a significant research collaboration and licensing agreement with Ascidian Therapeutics, a pioneering biotechnology firm…
Read More
In a significant advancement for the field of oncology, a collaborative study led by investigators at the Johns Hopkins Kimmel…
Read More
In a significant advancement for the field of molecular oncology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel…
Read More
Investigators at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg School of Public Health have identified a…
Read More